The experimental validation of fundamental thought experiments in quantum mechanics has profoundly advanced quantum science ...

After a lackluster play-calling debut for Carolina in week one of the 2026 preseason, Brad Idzik showed he could adapt and ...

President Donald Trump‘s strategy toward Iran raises questions about his grip on reality. Each claim of impending peace, followed by further military engagement, has led to allegations that the ...

First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant non-small cell lung cancer (NSCLC), providing a safe and effective oral targeted ...

Before the discovery of newer options and combinations, chemotherapy that included platinum medications like cisplatin or carboplatin was the first choice, says Christopher Wee, MD, a genitourinary ...

New recommendations by a European panel introduce first-line immunotherapy for hard-to-treat lung, thyroid, and gastrointestinal cancers, particularly in populations with specific genetic drivers or ...

Ready to unlock your full math potential? 🎓Subscribe for clear, fun, and easy-to-follow lessons that will boost your skills, build your confidence, and help you master math like a genius—one step at ...

Biliary tract cancers, including intrahepatic, perihilar, and extrahepatic cholangiocarcinoma and gallbladder cancer, are among the most aggressive gastrointestinal malignancies. Treatment options ...

Neo Space Group (NSG), a PIF company and Saudi Arabian space services provider, and Thai Airways (THAI) have announced that NSG Skywaves – the Group’s advanced in-flight connectivity (IFC) solution ...

Abstract: This paper presents the design and implementation of an advanced high speed line-following robot intended to support applied education in robotics and mechatronics engineering. The platform ...

In August, Zongertinib received FDA approval for previously treated HER2-mutant NSCLC. It now shows efficacy in first-line treatment, with a 77% objective response rate and 96% disease control rate.